Regulus Therapeutics Inc.

RGLS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$38,528$23,767$24,228$60,383
Short-Term Investments$37,249$0$14,932$0
Receivables$0$0$0$0
Inventory$0$3,010$3,010$3,010
Other Curr. Assets$3,077$62$62$62
Total Curr. Assets$82,345$28,179$44,079$65,235
Property Plant & Equip (Net)$1,811$2,538$2,575$2,845
Goodwill$0$0$0$0
Intangibles$25$33$62$83
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$291
Total NC Assets$1,836$2,571$2,637$3,219
Other Assets$0$0$0$0
Total Assets$84,181$30,750$46,716$68,454
Liabilities
Payables$947$204$175$285
Short-Term Debt$0$1,334$4,511$589
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0-$589
Other Curr. Liab.$5,041$5,358$2,553$706
Total Curr. Liab.$7,499$8,508$11,657$5,227
LT Debt$0$0$0$4,673
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$1,179
Total NC Liab.$274$1,055$1,768$8,269
Other Liabilities$0$0$0$0
Cap. Leases$274$1,055$1,768$2,417
Total Liabilities$7,773$9,563$13,425$13,496
Equity
Pref Stock$5$5$5$5
Common Stock$66$20$17$146
Retained Earnings-$559,571-$513,213-$483,176-$454,853
AOCI$50$0-$12$0
Other Equity$0$0$0$0
Total Equity$76,408$21,187$33,291$54,958
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$84,181$30,750$46,716$68,454
Net Debt-$38,528-$22,433-$19,717-$55,121
Regulus Therapeutics Inc. (RGLS) Financial Statements & Key Stats | AlphaPilot